tazarotene and Xeroderma studies

tazarotene and Xeroderma

tazarotene has been researched along with Xeroderma in 5 studies

tazarotene: a topical acetylenic retinoid; a topical kerytolytic
tazarotene : The ethyl ester of tazarotenic acid. A prodrug for tazarotenic acid, it is used for the treatment of psoriasis, acne, and sun-damaged skin.

Research Excerpts

Excerpt	Relevance	Reference
"We describe a patient with recessive ichthyosis for whom daily application of topical tazarotene produced rapid and persistent improvement of bilateral lower eyelid ectropion without adverse effects."	7.79	Topical tazarotene for the treatment of ectropion in ichthyosis. ( Choate, KA; Craiglow, BG; Milstone, LM, 2013)
"We describe a patient with recessive ichthyosis for whom daily application of topical tazarotene produced rapid and persistent improvement of bilateral lower eyelid ectropion without adverse effects."	3.79	Topical tazarotene for the treatment of ectropion in ichthyosis. ( Choate, KA; Craiglow, BG; Milstone, LM, 2013)

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	4 (80.00)	29.6817
2010's	1 (20.00)	24.3611
2020's	0 (0.00)	2.80

Timeframe

Studies, this research(%)

All Research%

pre-1990

0 (0.00)

18.7374

1990's

0 (0.00)

18.2507

2000's

4 (80.00)

29.6817

2010's

1 (20.00)

24.3611

2020's

0 (0.00)

2.80

Authors

Authors	Studies
Craiglow, BG	1
Choate, KA	1
Milstone, LM	1
Marulli, GC	1
Campione, E	1
Chimenti, MS	1
Terrinoni, A	1
Melino, G	1
Bianchi, L	1
Henno, A	1
Hua, MT	1
de la Brassinne, M	1
Barbarot, S	1
Acher-Chenebaux, A	1
Stalder, JF	1
Nguyen, V	1
Cunningham, BB	1
Eichenfield, LF	1
Alió, AB	1
Buka, RL	1

Studies

Craiglow, BG

Choate, KA

Milstone, LM

Marulli, GC

Campione, E

Chimenti, MS

Terrinoni, A

Melino, G

Bianchi, L

Henno, A

Hua, MT

de la Brassinne, M

Barbarot, S

Acher-Chenebaux, A

Stalder, JF

Nguyen, V

Cunningham, BB

Eichenfield, LF

Alió, AB

Buka, RL

Reviews

1 review available for tazarotene and Xeroderma

Article	Year
[Medication of the month. Tazarotene 0.05%-0.1% (Zorac)]. Revue medicale de Liege, 2003, Volume: 58, Issue:11 Topics: Administration, Topical; Dermatologic Agents; Dose-Response Relationship, Drug; Humans; Ichthyosis;	2003

Article

Year

[Medication of the month. Tazarotene 0.05%-0.1% (Zorac)].

Revue medicale de Liege, 2003, Volume: 58, Issue:11

Topics: Administration, Topical; Dermatologic Agents; Dose-Response Relationship, Drug; Humans; Ichthyosis;

2003

Trials

1 trial available for tazarotene and Xeroderma

Article	Year
[Topical tazarotene for severe congenital ichthyosis]. Annales de dermatologie et de venereologie, 2006, Volume: 133, Issue:1 Topics: Administration, Topical; Adolescent; Adult; Child; Child, Preschool; Female; Humans; Ichthyosis; Inf	2006

Article

Year

[Topical tazarotene for severe congenital ichthyosis].

Annales de dermatologie et de venereologie, 2006, Volume: 133, Issue:1

Topics: Administration, Topical; Adolescent; Adult; Child; Child, Preschool; Female; Humans; Ichthyosis; Inf

2006

Other Studies

3 other studies available for tazarotene and Xeroderma

Article	Year
Topical tazarotene for the treatment of ectropion in ichthyosis. JAMA dermatology, 2013, Volume: 149, Issue:5 Topics: Administration, Cutaneous; Aged; Ectropion; Female; Humans; Ichthyosis; Keratolytic Agents; Nicotini	2013
Type I lamellar ichthyosis improved by tazarotene 0.1% gel. Clinical and experimental dermatology, 2003, Volume: 28, Issue:4 Topics: Administration, Topical; Adult; Dermatologic Agents; Female; Gels; Humans; Ichthyosis; Nicotinic Aci	2003
Treatment of ichthyosiform diseases with topically applied tazarotene: risk of systemic absorption. Journal of the American Academy of Dermatology, 2007, Volume: 57, Issue:5 Suppl Topics: Administration, Topical; Adolescent; Child; Child, Preschool; Dermatologic Agents; Female; Humans; I	2007

Article

Year

Topical tazarotene for the treatment of ectropion in ichthyosis.

JAMA dermatology, 2013, Volume: 149, Issue:5

Topics: Administration, Cutaneous; Aged; Ectropion; Female; Humans; Ichthyosis; Keratolytic Agents; Nicotini

2013

Type I lamellar ichthyosis improved by tazarotene 0.1% gel.

Clinical and experimental dermatology, 2003, Volume: 28, Issue:4

Topics: Administration, Topical; Adult; Dermatologic Agents; Female; Gels; Humans; Ichthyosis; Nicotinic Aci

2003

Treatment of ichthyosiform diseases with topically applied tazarotene: risk of systemic absorption.

Journal of the American Academy of Dermatology, 2007, Volume: 57, Issue:5 Suppl

Topics: Administration, Topical; Adolescent; Child; Child, Preschool; Dermatologic Agents; Female; Humans; I

2007